-
Something wrong with this record ?
Meis transcription factors regulate cardiac conduction system development and adult function
N. Muñoz-Martín, A. Simon-Chica, C. Díaz-Díaz, V. Cadenas, S. Temiño, I. Esteban, A. Ludwig, B. Schormair, J. Winkelmann, V. Olejnickova, D. Sedmera, D. Filgueiras-Rama, M. Torres
Language English Country England, Great Britain
Document type Journal Article
Grant support
SC1-BHC-07-2019
European Commission H2020 Program
Spanish
PGC2018-096486-B-I00
Ministerio de Ciencia e Innovación
P2022/BMD-7245
Comunidad de Madrid
the Ministry of Education, Youth and Sports
207029
of the Czech Republic
18-03461S
Czech Science Foundation
100010434
'la Caixa' Foundation Severo Ochoa PhD Fellowship
7667
EMBO
CNIC
CEX2020-001041-S
Ministerio de Ciencia e Innovación and the Pro CNIC Foundation
PubMed
39691060
DOI
10.1093/cvr/cvae258
Knihovny.cz E-resources
- MeSH
- Action Potentials MeSH
- Phenotype MeSH
- Homeodomain Proteins * genetics metabolism MeSH
- Myocytes, Cardiac * metabolism pathology MeSH
- Myocardial Contraction MeSH
- Mice, Knockout MeSH
- Sinoatrial Node metabolism physiopathology MeSH
- Heart Conduction System * metabolism physiopathology growth & development MeSH
- Arrhythmias, Cardiac physiopathology metabolism genetics MeSH
- Heart Rate * MeSH
- Myeloid Ecotropic Viral Integration Site 1 Protein * genetics metabolism deficiency MeSH
- Age Factors MeSH
- Heart Defects, Congenital metabolism genetics physiopathology MeSH
- Gene Expression Regulation, Developmental MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
AIMS: The cardiac conduction system (CCS) is progressively specified during development by interactions among a discrete number of transcription factors (TFs) that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain TFs with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations and alterations of cardiac electrical activity; however, the basis for these alterations has not been established. Here, we studied the role of Meis TFs in cardiomyocyte development and function during mouse development and adult life. METHODS AND RESULTS: We studied Meis1 and Meis2 conditional deletion mouse models that allowed cardiomyocyte-specific elimination of Meis function during development and inducible elimination of Meis function in cardiomyocytes of the adult CCS. We studied cardiac anatomy, contractility, and conduction. We report that Meis factors are global regulators of cardiac conduction, with a predominant role in the CCS. While constitutive Meis deletion in cardiomyocytes led to congenital malformations of the arterial pole and atria, as well as defects in ventricular conduction, Meis elimination in cardiomyocytes of the adult CCS produced sinus node dysfunction and delayed atrio-ventricular conduction. Molecular analyses unravelled Meis-controlled molecular pathways associated with these defects. Finally, we studied in transgenic mice the activity of a Meis1 human enhancer related to an single-nucleotide polymorphism (SNP) associated by Genome-wide association studies (GWAS) to PR (P and R waves of the electrocardiogram) elongation and found that the transgene drives expression in components of the atrio-ventricular conduction system. CONCLUSION: Our study identifies Meis TFs as essential regulators of the establishment of cardiac conduction function during development and its maintenance during adult life. In addition, we generated animal models and identified molecular alterations that will ease the study of Meis-associated conduction defects and congenital malformations in humans.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016063
- 003
- CZ-PrNML
- 005
- 20250731091456.0
- 007
- ta
- 008
- 250708s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/cvr/cvae258 $2 doi
- 035 __
- $a (PubMed)39691060
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Muñoz-Martín, Noelia $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain
- 245 10
- $a Meis transcription factors regulate cardiac conduction system development and adult function / $c N. Muñoz-Martín, A. Simon-Chica, C. Díaz-Díaz, V. Cadenas, S. Temiño, I. Esteban, A. Ludwig, B. Schormair, J. Winkelmann, V. Olejnickova, D. Sedmera, D. Filgueiras-Rama, M. Torres
- 520 9_
- $a AIMS: The cardiac conduction system (CCS) is progressively specified during development by interactions among a discrete number of transcription factors (TFs) that ensure its proper patterning and the emergence of its functional properties. Meis genes encode homeodomain TFs with multiple roles in mammalian development. In humans, Meis genes associate with congenital cardiac malformations and alterations of cardiac electrical activity; however, the basis for these alterations has not been established. Here, we studied the role of Meis TFs in cardiomyocyte development and function during mouse development and adult life. METHODS AND RESULTS: We studied Meis1 and Meis2 conditional deletion mouse models that allowed cardiomyocyte-specific elimination of Meis function during development and inducible elimination of Meis function in cardiomyocytes of the adult CCS. We studied cardiac anatomy, contractility, and conduction. We report that Meis factors are global regulators of cardiac conduction, with a predominant role in the CCS. While constitutive Meis deletion in cardiomyocytes led to congenital malformations of the arterial pole and atria, as well as defects in ventricular conduction, Meis elimination in cardiomyocytes of the adult CCS produced sinus node dysfunction and delayed atrio-ventricular conduction. Molecular analyses unravelled Meis-controlled molecular pathways associated with these defects. Finally, we studied in transgenic mice the activity of a Meis1 human enhancer related to an single-nucleotide polymorphism (SNP) associated by Genome-wide association studies (GWAS) to PR (P and R waves of the electrocardiogram) elongation and found that the transgene drives expression in components of the atrio-ventricular conduction system. CONCLUSION: Our study identifies Meis TFs as essential regulators of the establishment of cardiac conduction function during development and its maintenance during adult life. In addition, we generated animal models and identified molecular alterations that will ease the study of Meis-associated conduction defects and congenital malformations in humans.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a transkripční faktor Meis1 $x genetika $x metabolismus $x nedostatek $7 D000075064
- 650 12
- $a homeodoménové proteiny $x genetika $x metabolismus $7 D018398
- 650 12
- $a kardiomyocyty $x metabolismus $x patologie $7 D032383
- 650 12
- $a převodní systém srdeční $x metabolismus $x patofyziologie $x růst a vývoj $7 D006329
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a vývojová regulace genové exprese $7 D018507
- 650 _2
- $a akční potenciály $7 D000200
- 650 12
- $a srdeční frekvence $7 D006339
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a kontrakce myokardu $7 D009200
- 650 _2
- $a srdeční arytmie $x patofyziologie $x metabolismus $x genetika $7 D001145
- 650 _2
- $a vrozené srdeční vady $x metabolismus $x genetika $x patofyziologie $7 D006330
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a nodus sinuatrialis $x metabolismus $x patofyziologie $7 D012849
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Simon-Chica, Ana $u Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000206640397
- 700 1_
- $a Díaz-Díaz, Covadonga $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000320306456
- 700 1_
- $a Cadenas, Vanessa $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain
- 700 1_
- $a Temiño, Susana $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain
- 700 1_
- $a Esteban, Isaac $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $1 https://orcid.org/0000000335301850
- 700 1_
- $a Ludwig, Andreas $u Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, 17 Fahrstraße, Erlangen 91054, Germany
- 700 1_
- $a Schormair, Barbara $u Institute of Neurogenomics, Helmholtz-Zentrum, 1 Ingolstädter Landstraße, Neuherberg 85764, Germany $1 https://orcid.org/0000000309425243
- 700 1_
- $a Winkelmann, Juliane $u Institute of Neurogenomics, Helmholtz-Zentrum, 1 Ingolstädter Landstraße, Neuherberg 85764, Germany
- 700 1_
- $a Olejnickova, Veronika $u First Faculty of Medicine, Institute of Anatomy, Charles University, U Nemocnice 3, Praha 2, 128 00, Czech Republic $1 https://orcid.org/0000000209911420 $7 mub2015894084
- 700 1_
- $a Sedmera, David $u First Faculty of Medicine, Institute of Anatomy, Charles University, U Nemocnice 3, Praha 2, 128 00, Czech Republic $1 https://orcid.org/0000000268283671 $7 xx0037135
- 700 1_
- $a Filgueiras-Rama, David $u Novel Arrhythmogenic Mechanisms Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain $u Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Calle del Prof Martín Lagos, Madrid 28040, Spain $1 https://orcid.org/0000000159092454
- 700 1_
- $a Torres, Miguel $u Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 3 Melchor Fernández Almagro, Madrid 28029, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 3-5 Av. Monforte de Lemos, Madrid 28029, Spain $1 https://orcid.org/0000000309064767
- 773 0_
- $w MED00009440 $t Cardiovascular research $x 1755-3245 $g Roč. 121, č. 2 (2025), s. 311-323
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39691060 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091450 $b ABA008
- 999 __
- $a ok $b bmc $g 2366722 $s 1253188
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 121 $c 2 $d 311-323 $e 20250422 $i 1755-3245 $m Cardiovascular research $n Cardiovasc Res $x MED00009440
- GRA __
- $a SC1-BHC-07-2019 $p European Commission H2020 Program
- GRA __
- $p Spanish
- GRA __
- $a PGC2018-096486-B-I00 $p Ministerio de Ciencia e Innovación
- GRA __
- $a P2022/BMD-7245 $p Comunidad de Madrid
- GRA __
- $p the Ministry of Education, Youth and Sports
- GRA __
- $a 207029 $p of the Czech Republic
- GRA __
- $a 18-03461S $p Czech Science Foundation
- GRA __
- $a 100010434 $p 'la Caixa' Foundation Severo Ochoa PhD Fellowship
- GRA __
- $a 7667 $p EMBO
- GRA __
- $p CNIC
- GRA __
- $a CEX2020-001041-S $p Ministerio de Ciencia e Innovación and the Pro CNIC Foundation
- LZP __
- $a Pubmed-20250708